Sensible
Latest round
- Series A
Last raised
- Oct 2026
Total raised
- $27M
Investors
- 9
About Sensible
Founded in 2021, Sensible is a biotechnology company that develops cell-based mRNA design, optimization, and manufacturing platform for therapeutic applications.
Who invested in Sensible
9 investors across 1 round
See all investors in Sensible
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2026
Amount
$27M
Investors
Questions about Sensible
Who invested in Sensible?
Sensible has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sensible raised?
Sensible has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sensible last raise money?
Sensible's most recent round on record is a Series A, in Oct 2026.
What does Sensible do?
Founded in 2021, Sensible is a biotechnology company that develops cell-based mRNA design, optimization, and manufacturing platform for therapeutic applications.
Where is Sensible headquartered?
Sensible is headquartered in UK.
Which VCs invest in companies like Sensible?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Sensible's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sensible? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.